Medical Research News and Research

RSS

A game-changing collaboration to accelerate drug development for Alzheimer's disease

The Critical Path Institute's (C-Path) Critical Path for Alzheimer's Disease (CPAD) Consortium today announced its participation as a Partner with the Alzheimer's Disease Data Initiative (ADDI), a 501(c)(3) medical research organization which launched today.

18 Nov 2020

Stronger relationships between nursing homes and health systems can enhance patient care

In a new editorial in the Journal of the American Geriatrics Society, Kathleen Unroe, M.D., MHA, a geriatrician, is advocating for stronger relationships between health systems and nursing homes to provide better care for patients in times of crisis and during day-to-day operations.

17 Nov 2020

Researchers decode brain maps of human color perception

Researchers at the National Eye Institute (NEI) have decoded brain maps of human color perception. The findings, published today in Current Biology, open a window into how color processing is organized in the brain, and how the brain recognizes and groups colors in the environment.

17 Nov 2020

New stroke ambulance in New South Wales could save many lives

Stroke Foundation has welcomed today’s announcement on a new stroke ambulance (or mobile stroke unit) in New South Wales.

17 Nov 2020

Exposure to low-level blasts affects the brains of military and law-enforcement personnel

Military and law-enforcement personnel repeatedly exposed to low-level blasts have significant brain changes – including an increased level of brain injury and inflammation – compared with a control group, a new study has found.

16 Nov 2020

Promising new compounds to potentially treat novel coronaviruses identified

Researchers at the University of Maryland School of Medicine and School of Pharmacy have discovered new drug compounds to potentially treat the novel coronavirus that causes COVID-19.

15 Nov 2020

Promising MS drug may make the debilitating disease worse

A drug that has shown promise for treating multiple sclerosis may actually make the debilitating disease worse, new research from the University of Virginia School of Medicine suggests.

15 Nov 2020

Antidepressant may prevent worsening of COVID-19 infection, study suggests

The antidepressant fluvoxamine appears to prevent COVID-19 infections from worsening and may help keep patients out of the hospital, a trial based on research from the University of Virginia School of Medicine suggests.

15 Nov 2020

Transmission of SARS-CoV-2 among US marine recruits after quarantine: A case study

A team of researchers at the Naval Medical Research Center, Silver Spring, USA, analyzed the risk of transmission of SARS-CoV-2 among marine recruits. Their study titled, “SARS-CoV-2 Transmission among Marine Recruits during Quarantine,” was published in the latest issue of the New England Journal of Medicine.

15 Nov 2020

Individuals with spinal cord injury show improvements in mobility with exoskeleton-assisted walking

Exoskeletal-assisted walking is safe, feasible, and effective in individuals disabled by spinal cord injury, according to the results of a federally funded multi-site randomized clinical trial.

12 Nov 2020

Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19

In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.

12 Nov 2020

New method using light-activated liposomes is safer, more direct to deliver CRISPR gene therapy

Light-activated liposomes could help to deliver CRISPR gene therapy - and the method could prove safer and more direct than current methods.

12 Nov 2020

Researchers assess the risk of proton therapy for children with brain tumors

Adelaide is poised to open Australia's first proton therapy center in 2025, with children and young adults expected to be the main beneficiaries of more effective cancer treatment with fewer side effects.

12 Nov 2020

COVID-19 treatments for people with early infection should be prioritized

COVID-19 treatments for people with early infection are needed urgently, according to a JAMA Viewpoint article by National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., and colleagues.

11 Nov 2020

IU researcher awarded NCI grant to develop a drug for making radiation therapy more effective

An Indiana University Melvin and Bren Simon Comprehensive Cancer Center researcher has been awarded a five-year, $2.9 million grant from the National Cancer Institute to develop a drug that could make radiation therapy far more effective.

11 Nov 2020

Five important questions about Pfizer’s COVID-19 vaccine

Pfizer's announcement on Monday that its COVID-19 shot appears to keep nine in 10 people from getting the disease sent its stock price rocketing. Many news reports described the vaccine as if it were our deliverance from the pandemic, even though few details were released.

11 Nov 2020

Microbes in the lungs could influence lung cancer progression and prognosis

Bottom Line: Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer.

11 Nov 2020

Synthetic protein nanoparticle may treat aggressive brain cancer

A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

11 Nov 2020

Gene signature may help develop new therapies against advanced prostate cancer

Researchers have identified a genetic signature in localized prostate cancer that can predict whether the cancer is likely to spread, or metastasize, early in the course of the disease and whether it will respond to anti-androgen therapy, a common treatment for advanced disease.

11 Nov 2020

New model for predicting colon cancer risk in average risk individuals

Regenstrief Institute and Indiana University School of Medicine research scientists have developed and tested one of the first U.S.-based models to predict personal risk for advanced precancerous polyps and colon cancer in average risk individuals.

10 Nov 2020

Medical Research News and Research

A game-changing collaboration to accelerate drug development for Alzheimer's disease

Stronger relationships between nursing homes and health systems can enhance patient care

Researchers decode brain maps of human color perception

New stroke ambulance in New South Wales could save many lives

Exposure to low-level blasts affects the brains of military and law-enforcement personnel

Promising new compounds to potentially treat novel coronaviruses identified

Promising MS drug may make the debilitating disease worse

Antidepressant may prevent worsening of COVID-19 infection, study suggests

Transmission of SARS-CoV-2 among US marine recruits after quarantine: A case study

Individuals with spinal cord injury show improvements in mobility with exoskeleton-assisted walking

Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19

New method using light-activated liposomes is safer, more direct to deliver CRISPR gene therapy

Researchers assess the risk of proton therapy for children with brain tumors

COVID-19 treatments for people with early infection should be prioritized

IU researcher awarded NCI grant to develop a drug for making radiation therapy more effective

Five important questions about Pfizer’s COVID-19 vaccine

Microbes in the lungs could influence lung cancer progression and prognosis

Synthetic protein nanoparticle may treat aggressive brain cancer

Gene signature may help develop new therapies against advanced prostate cancer

New model for predicting colon cancer risk in average risk individuals

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News